FDA Recalls Zantac as Posing a Cancer Risk

Have you or a loved one taken Zantac for GERD, reflux or heartburn?
On April 1, 2020, the Food and Drug Administration ordered Zantac products removed from the marketplace due to their being contaminated with a probable human carcinogen known known as N-Nitrosodimethylamine (NDMA). This includes the drugs Zantac, Zantac OTC, and generic ranitidine.

Over 60 million Americans experience heartburn at least once a month with 15 million experiencing symptoms once a day according to the American College of Gastroenterology. Zantac is the only drug that has shown evidence of harm. Other such popular drugs as Prilosec, Pepcid, Tagamet, Nexium or Prevacid are not implicated.

Did you develop cancer?
If you or someone you love has a history of taking Zantac on a regular basis over a period of time and developed any of these cancers, you should contact your doctor and us as soon as possible:

Stomach Cancer

Cancer in the small or large intestines

Colorectal Cancer

Esophageal Cancer

Kidney Cancer

Bladder Cancer

Liver Cancer

Prostate Cancer

Pancreatic cancer

Leukemia

Non-Hodgkin’s Lymphoma

Multiple Myeloma

Testicular Cancer

Uterine Cancer

In addition, if you or family member have any of these Zantac cancer symptoms, you should again see your doctor as soon as possible:

Unintentional Weight loss

Poor appetite

Nausea or vomiting

Bloody or tarry stools

Light colored or greasy stools

A change on bowel habits

Back pain

Yellowing of skin or eyes

Blood in the urine or dark urine

Painful urination

Itchy skin

New abdominal pain

What Legal Recourse May You Have?

If you or a loved one has suffered with any of these cancers, or if you have a loved one who passed away from such cancers with a history of Zantac use, you may have a viable legal claim for compensation against the manufacturer. You should contact Steve Barrettat (215) 661-0400 or SBarrett@HRMML.comas soon as possible so that deadlines may be met for filing a lawsuit. He is already representing clients in this litigation against the manufacturers of Zantac for such claims as negligently and/or intentionally making the medication with NDMA and failure to warn about the potential cancer risk.